Featured Videos | view more
Dr. Robert H. Vonderheide, Director of the Abramson Cancer Center at Penn Medicine, reviews the triumphs and challenges of cancer therapy over the last quarter century, focusing on new tools and the motivation driving the focus on immunotherapy ...
On Thursday, April 23rd, C. William Hanson, MD, Chief Medical Information Officer and Mary Elizabeth Deleener, MBA, BSN, RN, Director of Network Telemedicine at Penn Medicine presented Best Practices for Telemedicine: The Provider and Patient Experience.
Featured Articles & Documents |view more
The wealth of information that’s become available over the last 10 to 20 years coupled with the rapid evolution of the technology that can analyze it has dramatically transformed neurogenetics.
Surgeons and oncologists within the Department of Surgery at Penn Medicine are using adjuvant hepatic artery infusion chemotherapy with systemic chemotherapy to prevent recurrence in patients with resected colorectal liver metastases...
Investigators in the Division of Gynecologic Oncology at Penn Medicine are conducting a clinical trial to investigate combination therapy with olaparib and AZD6738 in women with high grade serous ovarian or primary peritoneal and/or fallopian tube cancer.
Tuesday, May 26, 2020 3:53 PM
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.
Tuesday, May 26, 2020 10:39 AM
After examining data from large trials of autoimmune-disease medications called Interleukin-17 (IL-17) inhibitors, researchers at the Perelman School of Medicine at the University of Pennsylvania found individuals who took these treatments ...
Tuesday, May 19, 2020 4:47 PM
Senotherapy,” a treatment that uses small molecule drugs to target “senescent” cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models according to new research from a team led by Celeste ...
Monday, May 18, 2020 8:00 PM
Penn conducts COVID-19 antibody testing using an advanced chemoluminecent microparticle SARS-CoV-2 antibody immunoassay from Abbott Laboratories. Learn more about the intended uses and background of the Abbott immunoassay.
Monday, May 18, 2020 8:00 PM
Penn's Leonard Davis Institute of Health Economics explores how the COVID-19 pandemic has impacted opioid use disorder and overdose crisis.
Monday, May 4, 2020 8:00 PM
A task force from the Penn Airway Safety Committee has created Guidelines for the application of tracheostomy in COVID-19 patients.
Zoom platform - invitation link will be sent via email to registrants Thursday, June 18, 2020, 5 – 9:20pm Type of Event: CME Course, Conference Sponsor: Abramson Cancer Center Program Overview: This activity ...
Zoom.us Thursday, June 18, 2020, 5 – 9:20pm For virtual exhibit payment ONLY. Address: Zoom.us Type of Event: Other Sponsor: Abramson Cancer Center
Friday, October 30, 2020, 7am – 3:15pm Location: Jordan Medical Education Center Address: 3400 Civic Center Boulevard, Philadelphia PA, 19104 Type of Event: Conference Sponsor: Abramson Cancer Center ...